Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Anika Therapeutics Inc.

    NASDAQ: ANIK · Real-Time Price · USD
    11.11
    0.18 (1.65%)
    At close: Jun 16, 2025, 3:59 PM
    11.11
    0.00%
    After-hours: Jun 16, 2025, 04:04 PM EDT

    Anika Therapeutics Statistics

    Share Statistics

    Anika Therapeutics has 14.34M shares outstanding. The number of shares has increased by -4.59% in one year.

    Shares Outstanding

    n/a
    		 14.34M

    Shares Change (YoY)

    n/a
    		 -4.59%

    Shares Change (QoQ)

    n/a
    		 -3.21%

    Owned by Institutions (%)

    n/a
    		 84.84%

    Shares Floating

    n/a
    		 13.76M

    Failed to Deliver (FTD) Shares

    n/a
    		 1

    FTD / Avg. Volume

    n/a
    		 n/a

    Short Selling Information

    The latest short interest is 412.97K, so 2.88% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 412.97K

    Short % of Shares Out

    n/a
    		 2.88%

    Short % of Float

    n/a
    		 3.38%

    Short Ratio (days to cover)

    n/a
    		 6.07

    Valuation Ratios

    The PE ratio is -4.3 and the forward PE ratio is 1090. Anika Therapeutics's PEG ratio is 0.13.

    PE Ratio

    n/a
    		 -4.3

    Forward PE

    n/a
    		 1090

    PS Ratio

    n/a
    		 2.02

    Forward PS

    n/a
    		 0.7

    PB Ratio

    n/a
    		 1.57

    P/FCF Ratio

    n/a
    		 -103.95

    PEG Ratio

    n/a
    		 0.13
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Anika Therapeutics.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 4.88, with a Debt / Equity ratio of 0.17.

    Current Ratio

    n/a
    		 4.88

    Quick Ratio

    n/a
    		 3.85

    Debt / Equity

    n/a
    		 0.17

    Debt / EBITDA

    n/a
    		 8.59

    Debt / FCF

    n/a
    		 -11.12

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $416,343.75

    Profits Per Employee

    n/a
    		 $-195,781.25

    Employee Count

    n/a
    		 288

    Asset Turnover

    n/a
    		 0.59

    Inventory Turnover

    n/a
    		 1.84

    Taxes

    Income Tax

    n/a
    		 6.06M

    Effective Tax Rate

    n/a
    		 -219.39%

    Stock Price Statistics

    The stock price has increased by -57.25% in the last 52 weeks. The beta is 0.65, so Anika Therapeutics's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.65

    52-Week Price Change

    n/a
    		 -57.25%

    50-Day Moving Average

    n/a
    		 12.79

    200-Day Moving Average

    n/a
    		 17.59

    Relative Strength Index (RSI)

    n/a
    		 38.44

    Average Volume (20 Days)

    n/a
    		 68,792

    Income Statement

    In the last 12 months, Anika Therapeutics had revenue of 119.91M and earned -56.38M in profits. Earnings per share was -3.83.

    Revenue

    n/a
    		 119.91M

    Gross Profit

    n/a
    		 76M

    Operating Income

    n/a
    		 -5.1M

    Net Income

    n/a
    		 -56.38M

    EBITDA

    n/a
    		 3.02M

    EBIT

    n/a
    		 -5.1M

    Earnings Per Share (EPS)

    n/a
    		 -3.83
    Full Income Statement

    Balance Sheet

    The company has 55.63M in cash and 25.93M in debt, giving a net cash position of 29.7M.

    Cash & Cash Equivalents

    n/a
    		 55.63M

    Total Debt

    n/a
    		 25.93M

    Net Cash

    n/a
    		 29.7M

    Retained Earnings

    n/a
    		 71.67M

    Total Assets

    n/a
    		 190.6M

    Working Capital

    n/a
    		 84.61M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was 5.4M and capital expenditures -7.73M, giving a free cash flow of -2.33M.

    Operating Cash Flow

    n/a
    		 5.4M

    Capital Expenditures

    n/a
    		 -7.73M

    Free Cash Flow

    n/a
    		 -2.33M

    FCF Per Share

    n/a
    		 -0.16
    Full Cash Flow Statement

    Margins

    Gross margin is 63.38%, with operating and profit margins of -4.25% and -47.02%.

    Gross Margin

    n/a
    		 63.38%

    Operating Margin

    n/a
    		 -4.25%

    Pretax Margin

    n/a
    		 -2.31%

    Profit Margin

    n/a
    		 -47.02%

    EBITDA Margin

    n/a
    		 2.52%

    EBIT Margin

    n/a
    		 -4.25%

    FCF Margin

    n/a
    		 -1.94%

    Dividends & Yields

    ANIK does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for ANIK is $19, which is 71% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $19

    Price Target Difference

    n/a
    		 71%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 1
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 3.73

    Piotroski F-Score

    n/a
    		 4

    Add to Watchlist